Chemo Pharma Laboratories Limited, a pharmaceutical company listed on the Bombay Stock Exchange, has announced significant changes in its compliance leadership. The company, in a regulatory filing on September 12, 2025, disclosed the resignation of its Company Secretary and Compliance Officer and the immediate appointment of a successor.

Resignation of Ms. Bhawna Rajput

Ms. Bhawna Rajput (ACS 72357) has stepped down from her role as Company Secretary and Compliance Officer of Chemo Pharma Laboratories Limited. According to the company's statement, Ms. Rajput cited preoccupation with other assignments as the reason for her departure. Her resignation was tendered and accepted on September 12, 2025, with immediate effect.

Appointment of Mr. Aditya Agarwal

In a swift transition, the Board of Directors of Chemo Pharma Laboratories Limited convened a meeting on the same day and approved the appointment of Mr. Aditya Agarwal (ACS 53202) as the new Company Secretary and Compliance Officer. Mr. Agarwal's appointment also took effect from September 12, 2025, ensuring continuity in this critical compliance role.

About the New Appointee

Mr. Aditya Agarwal brings a strong educational background and relevant expertise to his new position. He is a qualified Company Secretary with specialized knowledge in legal, secretarial, and listing compliances. His academic credentials include an MBA and an M.Com degree, which complement his professional qualifications.

The company highlighted Mr. Agarwal's experience and his proven ability to independently manage statutory requirements while contributing to organizational growth. He is described as a collaborative team player with an ownership mindset, focused on delivering high-quality strategic solutions to complex challenges.

Board Meeting Details

The Board meeting where these changes were approved commenced at 3:15 PM and concluded at 3:45 PM on September 12, 2025, at the registered office of the company. Mr. Agarwal is not related to any existing directors of Chemo Pharma Laboratories Limited, maintaining the independence of the compliance function.

Regulatory Compliance

These leadership changes were disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has assured that all necessary formalities regarding Ms. Rajput's resignation will be completed in due course.

Chemo Pharma Laboratories Limited, with its registered office in Kalyan, Maharashtra, and corporate office in Ahmedabad, Gujarat, continues to operate under the leadership of Mr. Ruchit Mehta, the Managing Director and Chief Executive Officer.

Chemo Pharma Laboratories Limited has announced the receipt of a significant request from one of its Promoter Group Shareholders. Ms. Shanta Somani has formally sought reclassification from the 'Promoter Group Shareholder' category to the 'Public Shareholder' category, as per the regulations set by the Securities and Exchange Board of India (SEBI).

Request Details

The company disclosed that Ms. Somani submitted her request on August 11, 2025, at 2:57 PM. This move is in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, commonly known as SEBI (LODR) Regulations, 2015.

Next Steps

Chemo Pharma Laboratories has stated that the reclassification request will be taken up for consideration by the company's Board of Directors. The board is expected to discuss this matter in an upcoming meeting, which is yet to be scheduled.

Management Statement

Mr. Ruchit Mehta, Managing Director & Chief Executive Officer of Chemo Pharma Laboratories Limited, confirmed the receipt of the request letter. In the company's communication to the Bombay Stock Exchange, he stated:

"The request letter submitted by Ms. Shanta Somani (Promoter Group Shareholder) will be considered by the Board of Directors of the Company in the ensuing Board Meeting to be scheduled shortly."

Regulatory Compliance

The company has assured stakeholders that it will adhere to all necessary regulatory procedures. An intimation regarding the upcoming Board Meeting will be disclosed by the company in due course, ensuring transparency in the process.

About Chemo Pharma Laboratories Limited

Chemo Pharma Laboratories Limited is a publicly listed company on the Bombay Stock Exchange. The company's registered office is located in Kalyan, Thane district, while its corporate office is situated in Fort, Mumbai.

Investors and market observers will be keenly watching for further developments on this reclassification request, as such changes can potentially impact the company's shareholding structure and market perception. Chemo Pharma Laboratories Limited has committed to providing updates as the process unfolds, maintaining open communication with its shareholders and the public.